CPHI vs PODD · rev $4.5M vs P/E 34, rev $2.07B
China Pharma Holdings Inc (CPHI) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CPHI currently screens at market cap $29.0M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CPHI and PODD stock pages for the full models.
Not investment advice.